CytoSolve, Inc. is a US-based corporation, which has created a technology platform for in silico drug discovery and development through quantitative modeling of complex molecular pathways - potentially supplanting the need for animal testing and reducing the time it takes for drugs or nutraceuticals to be brought to market. CytoSolve specializes in the use of its technology platform for discovery of multi-combination compounds for both the prevention and cure of major diseases such as cancer, obesity, inflammation and others.
Cambridge, MA, USAcytosolve.comInaccurate data? Flag it here.
Open jobs at CytoSolve